- Home
- JVA vs AYTU Comparison
JVA vs AYTU Comparison
Compare JVA & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- AYTU
- Stock Information
- Founded
- JVA 1971
- AYTU N/A
- Country
- JVA United States
- AYTU United States
- Employees
- JVA N/A
- AYTU N/A
- Industry
- JVA Packaged Foods
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- AYTU Health Care
- Exchange
- JVA Nasdaq
- AYTU Nasdaq
- Market Cap
- JVA 25.7M
- AYTU 23.0M
- IPO Year
- JVA 2005
- AYTU N/A
- Fundamental
- Price
- JVA $4.00
- AYTU $2.12
- Analyst Decision
- JVA
- AYTU Strong Buy
- Analyst Count
- JVA 0
- AYTU 3
- Target Price
- JVA N/A
- AYTU $9.17
- AVG Volume (30 Days)
- JVA 57.1K
- AYTU 148.2K
- Earning Date
- JVA 09-12-2025
- AYTU 11-13-2025
- Dividend Yield
- JVA N/A
- AYTU N/A
- EPS Growth
- JVA 64.91
- AYTU N/A
- EPS
- JVA 0.32
- AYTU N/A
- Revenue
- JVA $89,748,681.00
- AYTU $66,382,000.00
- Revenue This Year
- JVA N/A
- AYTU N/A
- Revenue Next Year
- JVA N/A
- AYTU $29.12
- P/E Ratio
- JVA $12.56
- AYTU N/A
- Revenue Growth
- JVA 17.92
- AYTU 1.84
- 52 Week Low
- JVA $2.75
- AYTU $0.95
- 52 Week High
- JVA $9.93
- AYTU $2.82
- Technical
- Relative Strength Index (RSI)
- JVA 36.99
- AYTU 42.46
- Support Level
- JVA $3.91
- AYTU $2.23
- Resistance Level
- JVA $4.65
- AYTU $2.31
- Average True Range (ATR)
- JVA 0.22
- AYTU 0.12
- MACD
- JVA -0.03
- AYTU -0.02
- Stochastic Oscillator
- JVA 12.80
- AYTU 4.66
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.